Donating to the Cancer Impact Booster
Are you interested in boosting our investment in cutting-edge cancer start-ups?

£8m
Seed Fund committed to date
£32.9m
co-investment secured to date
26
new investments to date
2
pending investments
Fast-tracking research into patient impact
Through advances in technology, we’re on the threshold of a golden age of scientific progress against cancer. Start-ups are one of the fastest ways of translating that progress into impact for patients.
But there’s a funding gap between cutting-edge academic cancer research and a start-up becoming ready for commercial investment. Too many potential treatments, devices and innovations are lost here.
We have an opportunity to deliver huge future impact for patients by supporting start-ups through this gap. Which is why we committed £15m to a Seed Fund which accelerates high-potential, early-stage innovations into patient impact through seed funding, expert networks and business building support. Any financial returns generated are reinvested in the fund and into more cancer research.
We’re proud to be supporting Cancer Research UK’s work to help bridge the gap between discovery science and the clinic.
Speak to the Philanthropy team to find out more
